Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
暂无分享,去创建一个
Kai Ma | Nian Xiong | Zhicheng Lin | Tao Wang | Ling Liu | N. Xiong | Jinsha Huang | Jinsha Huang | Yan Shen | Yun Xia | Guoxin Zhang | Chao Han | Fang Wan | Tao Wang | Ling Liu | Chao Han | Guoxin Zhang | Luxi Wang | Shiyi Guo | Xingfang Guo | Yun Xia | Fang Wan | Yan Shen | Zhicheng Lin | Kai Ma | Xingfang Guo | Shiyi Guo | Luxi Wang
[1] B. Vellas,et al. Weight loss in Alzheimer disease. , 2000, The American journal of clinical nutrition.
[2] Rosanna Abbate,et al. Adherence to Mediterranean diet and health status: meta-analysis , 2008, BMJ : British Medical Journal.
[3] K. Kashihara. Weight loss in Parkinson’s disease , 2006, Journal of Neurology.
[4] M. Unosson,et al. Does l‐dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease? , 2005, Acta neurologica Scandinavica.
[5] K. Krogh. Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .
[6] Klaus Mewes,et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease , 2003, Annals of neurology.
[7] H. Przuntek,et al. Predictors of gastric emptying in Parkinson's disease , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[8] C. Tanner,et al. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. , 2012, Parkinsonism & related disorders.
[9] K. Chan,et al. Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection Against MPP+ Toxicity in Neuronal Cells , 2009, Neurotoxicity Research.
[10] M. Katsuno,et al. Lower body mass index is associated with orthostatic hypotension in Parkinson's disease , 2017, Journal of the Neurological Sciences.
[11] Christian Plewnia,et al. Deep-brain-stimulation does not impair deglutition in Parkinson's disease. , 2012, Parkinsonism & related disorders.
[12] S. Kish,et al. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects , 1994, Brain Research.
[13] Johanna G. Kalf SP MSc,et al. Impact of drooling in Parkinson’s disease , 2007, Journal of Neurology.
[14] D. Ryglewicz,et al. Taste responses in patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[15] A. Westergren,et al. Weight stability in Parkinson's disease , 2016, Nutritional neuroscience.
[16] M. Unosson,et al. Avoidance of solid food in weight losing older patients with Parkinson's disease. , 2006, Journal of clinical nursing.
[17] Yaakov Stern,et al. Dementia in Parkinson's disease , 1994, Neurology.
[18] Nikolaus R. McFarland,et al. Weight Loss and Impact on Quality of Life in Parkinson’s Disease , 2015, PloS one.
[19] F. You,et al. The stimulatory effect of neuropeptide Y on growth hormone expression, food intake, and growth in olive flounder (Paralichthys olivaceus) , 2017, Fish Physiology and Biochemistry.
[20] H. Maas,et al. Assessment and treatment of malnutrition in Dutch geriatric practice: consensus through a modified Delphi study. , 2012, Age and ageing.
[21] R. Roth,et al. Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism , 2009, The Journal of Neuroscience.
[22] T. Hummel,et al. Olfactory disorders: the patients' view. , 2009, Rhinology.
[23] O. Rascol,et al. Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment , 1992, Clinical Autonomic Research.
[24] A. Tomkins,et al. Increased energy expenditure in Parkinson's disease. , 1990, BMJ.
[25] Dan Chen,et al. Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment , 2016, Molecular Neurobiology.
[26] E. Poehlman,et al. Free-living Daily Energy Expenditure in Patients with Parkinson's Disease , 1997, Neurology.
[27] K. Lyons,et al. MDS-UPDRS to assess non-motor symptoms after STN DBS for Parkinson's disease , 2016, The International journal of neuroscience.
[28] Chris Zarow,et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.
[29] P. Medcalf,et al. Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study. , 2005, Age and ageing.
[30] Andrea Mauri,et al. Special low‐protein foods ameliorate postprandial off in patients with advanced Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[31] J. Johanson,et al. Chronic constipation: a survey of the patient perspective , 2007, Alimentary pharmacology & therapeutics.
[32] M. Lanotte,et al. Motor and Nonmotor Symptom Follow-Up in Parkinsonian Patients after Deep Brain Stimulation of the Subthalamic Nucleus , 2007, European Neurology.
[33] Erkki Tukiainen,et al. Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in the general population in Finland. , 2005, Chemosphere.
[34] A. Lawrence,et al. Reward processing in health and Parkinson's disease: neural organization and reorganization. , 2004, Cerebral cortex.
[35] J. Holton,et al. Hypothalamic α‐synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.
[36] C. Mazzà,et al. Free‐living monitoring of Parkinson's disease: Lessons from the field , 2016, Movement disorders : official journal of the Movement Disorder Society.
[37] M. Vassallo,et al. Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade). , 2006, Parkinsonism & related disorders.
[38] S. Zimmerman,et al. Gender Differences in Mortality After Hip Fracture: The Role of Infection , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] P. Patil,et al. The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. , 2013, Parkinsonism & related disorders.
[40] S. Rehncrona,et al. Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years , 2008, Movement disorders : official journal of the Movement Disorder Society.
[41] J. Morley,et al. Assessment of protein energy malnutrition in older persons, Part II: Laboratory evaluation. , 2000, Nutrition.
[42] K. Westerterp,et al. Free‐living energy expenditure reduced after deep brain stimulation surgery for Parkinson’s disease , 2012, Clinical physiology and functional imaging.
[43] L. Schiffer,et al. Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.
[44] H. Berendse,et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell , 2001, Annals of neurology.
[45] E. Quigley,et al. Gastroparesis and Parkinson's disease: a systematic review. , 2012, Parkinsonism & related disorders.
[46] I Litvan,et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. , 2001, Archives of neurology.
[47] C. McIntyre,et al. Sources and effects of electrode impedance during deep brain stimulation , 2006, Clinical Neurophysiology.
[48] Michael Camilleri,et al. Methods for the assessment of small-bowel and colonic transit. , 2012, Seminars in nuclear medicine.
[49] Kelly L. Sullivan,et al. Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment , 2007, Current neurology and neuroscience reports.
[50] E. Poehlman. A review: exercise and its influence on resting energy metabolism in man. , 1989, Medicine and science in sports and exercise.
[51] D. Brooks,et al. Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study , 2008, Neurobiology of Disease.
[52] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[53] P. Krack,et al. Mechanisms of Body Weight Fluctuations in Parkinson’s Disease , 2014, Front. Neurol..
[54] B. Bloem,et al. Body mass index in Parkinson's disease: a meta-analysis. , 2012, Parkinsonism & related disorders.
[55] C. A. Álvarez Marcos,et al. Swallowing disorders in Parkinson's disease. , 2017, Acta otorrinolaringologica espanola.
[56] E. Oh,et al. Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD). , 2012, Archives of gerontology and geriatrics.
[57] C. Tanner,et al. Bowel movement frequency in late‐life and incidental Lewy bodies , 2007, Movement disorders : official journal of the Movement Disorder Society.
[58] S. Chung,et al. Factors contributing to malnutrition in patients with Parkinson's disease. , 2016, International journal of nursing practice.
[59] M. Canesi,et al. Is underweightness still a major problem in Parkinson's disease patients? , 2003, European Journal of Clinical Nutrition.
[60] R. Iacono,et al. The hypothalamus in Parkinson Disease , 1987, The Italian Journal of Neurological Sciences.
[61] R. Rafal,et al. Appetitive motivational deficits in individuals with Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[62] M. Thomas,et al. Dysphagia, a reversible cause not to be forgotten. , 1995, Postgraduate medical journal.
[63] J. H. Friedman,et al. Fatigue in Parkinson's disease: a nine‐year follow‐up , 2001, Movement disorders : official journal of the Movement Disorder Society.
[64] J. Llovet,et al. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome , 1991 .
[65] L. Forsgren,et al. Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study , 2011, Nutritional neuroscience.
[66] E. Cuny,et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight , 2004, Movement disorders : official journal of the Movement Disorder Society.
[67] E. Bézard,et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.
[68] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[69] L. Provinciali,et al. Rest energy expenditure in Parkinson's disease: role of disease progression and dopaminergic therapy. , 2013, Parkinsonism & related disorders.
[70] Yunqi Xu,et al. Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer’s Disease and Vascular Dementia: A Cross-Sectional Study , 2017, Front. Aging Neurosci..
[71] M. Kołaczkowski,et al. Sweet liking in patients with Parkinson's disease , 2013, Journal of the Neurological Sciences.
[72] A. Gasbarrini,et al. The role of small intestinal bacterial overgrowth in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[73] P. Mazzoni,et al. Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease , 2016, Journal of Clinical Movement Disorders.
[74] J. Johanson. Review of the treatment options for chronic constipation. , 2007, MedGenMed : Medscape general medicine.
[75] H. Berendse,et al. Prevalence of smell loss in Parkinson's disease--a multicenter study. , 2009, Parkinsonism & related disorders.
[76] M. Unosson,et al. Factors of importance for weight loss in elderly patients with Parkinson's disease , 2004, Acta neurologica Scandinavica.
[77] M. Mattson,et al. Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice , 2014, Neurobiology of Aging.
[78] S. Cummings,et al. The association of Parkinson’s disease with bone mineral density and fracture in older women , 2008, Osteoporosis International.
[79] J. Jankovic,et al. Low Body Weight in Parkinson's Disease , 1992, Southern medical journal.
[80] O. Tysnes,et al. Loss of independence in early Parkinson disease , 2016, Neurology.
[81] Dopaminergic agents and nutritional status in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[82] A. Mauri,et al. Mini Nutritional Assessment in patients with Parkinson's disease: correlation between worsening of the malnutrition and increasing number of disease-years , 2008, Nutritional neuroscience.
[83] J. Ferreira,et al. Dopamine agonist therapy in early Parkinson's disease. , 2008, The Cochrane database of systematic reviews.
[84] R. Sakakibara,et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. , 2012, Brain : a journal of neurology.
[85] Xiao-Ming Yin,et al. Leptin Protects against 6-Hydroxydopamine-induced Dopaminergic Cell Death via Mitogen-activated Protein Kinase Signaling* , 2007, Journal of Biological Chemistry.
[86] E. Cereda,et al. Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis , 2012, British Journal of Nutrition.
[87] H. Delemarre-van de Waal,et al. Developmental programming of energy balance and its hypothalamic regulation. , 2011, Endocrine reviews.
[88] C. Garrett,et al. Locus Coeruleus Is Involved in Weight Loss in a Rat Model of Parkinson's Disease: An Effect Reversed by Deep Brain Stimulation , 2013, Brain Stimulation.
[89] A. Melo,et al. Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients? , 2008, Parkinsonism & related disorders.
[90] Jian Liu,et al. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of α2-adrenoceptors in normal and medial forebrain bundle lesioned rats , 2010, Brain Research.
[91] M. Unosson,et al. Food Habits and Intake of Nutrients in Elderly Patients with Parkinson’s Disease , 2006, Gerontology.
[92] S. Fahn,et al. Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint , 1999, Movement disorders : official journal of the Movement Disorder Society.
[93] A. Lang,et al. Practical application of a low‐protein diet for Parkinson's disease , 1988, Neurology.
[94] G. Kerr,et al. Malnutrition in a Sample of Community-Dwelling People with Parkinson’s Disease , 2012, PloS one.
[95] M. Yamasaki,et al. The thermic response to food intake in persons with thoracic spinal cord injury , 2016, Journal of physical therapy science.
[96] K. Berridge,et al. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.
[97] E. Cereda,et al. Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review , 2010, Movement disorders : official journal of the Movement Disorder Society.
[98] P. Hogarth,et al. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. , 2005, Archives of neurology.
[99] P. Garcia-Lorda,et al. Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer's disease. , 2005, Clinical nutrition.
[100] Dag Aarsland,et al. Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.
[101] Jungsu S. Oh,et al. Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease , 2016, Neurobiology of Aging.
[102] G. Linazasoro,et al. Classifying risk factors for dyskinesia in Parkinson's disease. , 2010, Parkinsonism & related disorders.
[103] Graham K Kerr,et al. Prevalence of malnutrition in Parkinson's disease: a systematic review. , 2011, Nutrition reviews.
[104] J. Péron,et al. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[105] O. Rascol,et al. Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson’s Disease , 2010, CNS drugs.
[106] R. Munhoz,et al. The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics , 2010, Clinical Neurology and Neurosurgery.
[107] Z. Mari,et al. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. , 2016, JAMA neurology.
[108] J W Langston,et al. The hypothalamus in parkinson disease , 1978, Annals of neurology.
[109] J. Cauley,et al. Association Between Parkinson's Disease and Low Bone Density and Falls in Older Men: The Osteoporotic Fractures in Men Study , 2005, Journal of the American Geriatrics Society.
[110] P. Ritz,et al. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. , 2007, The journal of nutrition, health & aging.
[111] E. Quigley,et al. Gastrointestinal symptoms in Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.
[112] J. Lefaucheur,et al. Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD. , 2011, Sleep medicine.
[113] B. Sidenvall,et al. Case studies of food shopping, cooking and eating habits in older women with Parkinson's disease. , 2001, Journal of advanced nursing.
[114] Z. Andrews,et al. Therapeutic Advances in Endocrinology and Metabolism Review , 2022 .
[115] J. Salamone,et al. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine , 2002, Behavioural Brain Research.
[116] Marilena Aiello,et al. Body weight and food intake in Parkinson's disease. A review of the association to non-motor symptoms , 2015, Appetite.
[117] C. Mariani,et al. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation , 2003, Movement disorders : official journal of the Movement Disorder Society.
[118] A. Fasano,et al. Gastrointestinal dysfunction in Parkinson's disease , 2003, The Lancet Neurology.
[119] R. Doty,et al. Olfactory dysfunction in parkinsonism , 1988, Neurology.
[120] H. Reichmann,et al. Reduced Body Mass Index in Parkinson’s Disease: Contribution of Comorbid Depression , 2013, The Journal of nervous and mental disease.
[121] Adrian Danek,et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study , 2008, The Lancet Neurology.
[122] E. Moro,et al. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease , 1999, Neurology.
[123] J. Vardi,et al. Weight loss in patients treated long-term with levodopa Metabolic aspects , 1976, Journal of the Neurological Sciences.
[124] N. Teasdale,et al. Predictors of weight loss in Parkinson's disease: Is weight loss the chicken or the egg? , 2007, Movement disorders : official journal of the Movement Disorder Society.
[125] R. Paffenbarger,et al. Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.
[126] R. Rodnitzky,et al. Predictors of weight loss in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[127] M. Emre,et al. Cognitive impairment and dementia in Parkinson's disease: Practical issues and management , 2014, Movement disorders : official journal of the Movement Disorder Society.
[128] J. Elmquist,et al. Body weight is regulated by the brain: a link between feeding and emotion , 2005, Molecular Psychiatry.
[129] R. Palmiter,et al. Reward without Dopamine , 2003, The Journal of Neuroscience.
[130] L. Królicki,et al. Small intestine dysfunction in Parkinson’s disease , 2015, Journal of Neural Transmission.
[131] H. Berendse,et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.
[132] David J. Brooks,et al. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study , 2008, Experimental Neurology.
[133] Yong-Jie Li,et al. Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.
[134] C. Adler,et al. Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss , 2001, Movement disorders : official journal of the Movement Disorder Society.
[135] I. Miyai,et al. [Relationship between weight loss and dysphagia in patients with Parkinson's disease]. , 1999, Rinsho shinkeigaku = Clinical neurology.
[136] V. De Rosa,et al. Role of metabolism in neurodegenerative disorders. , 2016, Metabolism: clinical and experimental.
[137] R. Walker,et al. A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson's disease , 2010, BMC neurology.
[138] S. Woods,et al. Central nervous system control of food intake , 2000, Nature.
[139] J. Speakman,et al. Metabolic changes over the course of aging in a mouse model of tau deposition , 2016, Neurobiology of Aging.
[140] B. Bloem,et al. Parkinson's disease and osteoporosis. , 2013, Age and ageing.
[141] R. Strong,et al. Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease , 2013, PloS one.
[142] R. Strowd,et al. Weight change following deep brain stimulation for movement disorders , 2010, Journal of Neurology.
[143] W. Slade,et al. Megacolon and dilatation of the small bowel in parkinsonism. , 1951, Gastroenterology.
[144] E. Růžička,et al. Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[145] T. Iacono,et al. Weight, nutrition, food choice, and physical activity in adults with intellectual disability. , 2016, Journal of intellectual disability research : JIDR.
[146] R. Maxwell,et al. Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery. , 2005, Parkinsonism & related disorders.
[147] R. Pahwa,et al. Olfactory function in essential tremor , 1992, Neurology.
[148] C. Naylor,et al. Parkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort , 2004, Movement disorders : official journal of the Movement Disorder Society.
[149] D. Binder,et al. Effects of Deep Brain Stimulation on Autonomic Function , 2016, Brain sciences.
[150] J. Schwalb,et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[151] A. Zapf,et al. Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias , 2009, European journal of neurology.
[152] J. Sharma,et al. Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes. , 2012, Parkinsonism & related disorders.
[153] S. L. la Fleur,et al. Subthalamic nucleus stimulation does not influence basal glucose metabolism or insulin sensitivity in patients with Parkinson's disease , 2014, Front. Neurosci..
[154] Brittany D. Walls,et al. Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: A Meta-Analysis , 2015, Neuropsychology Review.
[155] M. Rodríguez-Violante,et al. Overweight is more prevalent in patients with Parkinson's disease. , 2012, Arquivos de neuro-psiquiatria.
[156] Y. Agid,et al. Biochemistry of the hypothalamus in Parkinson's disease , 1984, Neurology.
[157] M. Vassallo,et al. Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. , 2014, Neurodegenerative disease management.
[158] J. Sellin,et al. Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea , 2009, Alimentary pharmacology & therapeutics.
[159] B. Tang,et al. Simvastatin Induces Neuroprotection in 6‐OHDA‐Lesioned PC12 via the PI3K/AKT/Caspase 3 Pathway and Anti‐Inflammatory Responses , 2013, CNS neuroscience & therapeutics.
[160] D. Ricquier. Fundamental mechanisms of thermogenesis. , 2006, Comptes rendus biologies.
[161] M. Okun,et al. Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. , 2013, Parkinsonism & related disorders.
[162] R. Lister,et al. Oropharyngeal dysphagia and nutritional management , 2006, Current opinion in gastroenterology.
[163] S. Sherman,et al. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[164] E. Huang,et al. Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. , 2016, The American journal of pathology.
[165] M. Okun,et al. Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective Analysis , 2014, Dysphagia.
[166] A. Dunn,et al. Chronic alterations in jejunal myoelectric activity in rats due to MPTP. , 1987, The American journal of physiology.
[167] R. Djaldetti,et al. Gastric emptying in Parkinson's disease , 1996, Neurology.
[168] Emmanuel Cuny,et al. Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease , 2005, British Journal of Nutrition.
[169] H. Reichmann,et al. Chocolate consumption is increased in Parkinson’s disease , 2009, Journal of Neurology.
[170] A. Tomkins,et al. Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[171] Marjan Jahanshahi,et al. Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. , 2006, Parkinsonism & related disorders.
[172] D. Brooks. Safety and tolerability of COMT inhibitors , 2004, Neurology.
[173] L. Bour,et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial , 2013, The Lancet Neurology.
[174] C. Colosimo,et al. Constipation: an emerging risk factor for Parkinson's disease? , 2016, European journal of neurology.
[175] A. Krygowska-Wajs,et al. The effect of subthalamic deep brain stimulation on gastric motility in Parkinson's disease. , 2016, Parkinsonism & related disorders.
[176] Carmen Rodriguez-Blazquez,et al. Burden, perceived health status, and mood among caregivers of Parkinson's disease patients , 2008, Movement disorders : official journal of the Movement Disorder Society.
[177] P. Derost,et al. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. , 2007, Brain : a journal of neurology.
[178] C. Trenkwalder,et al. Body weight in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[179] D. Bowers,et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial , 2009, Annals of neurology.
[180] P J Garry,et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. , 1999, Nutrition.
[181] E. Wolińska-Witort,et al. Leptin and ghrelin concentrations and weight loss in Parkinson’s disease , 2010, Acta neurologica Scandinavica.
[182] R. Fisher,et al. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. , 2004, Gastroenterology.
[183] D. Michalek,et al. Weight change and body composition in patients with Parkinson's disease. , 1995, Journal of the American Dietetic Association.
[184] E. Růžička,et al. Sex, Food and Threat: Startling Changes after Subthalamic Stimulation in Parkinson's Disease , 2013, Brain Stimulation.
[185] C. Leitão,et al. Determinants of body weight regulation in humans. , 2016, Archives of endocrinology and metabolism.
[186] Ying Wang,et al. Malnutrition and associated factors in Chinese patients with Parkinson's disease: Results from a pilot investigation. , 2010, Parkinsonism & related disorders.
[187] J. Jankovic,et al. Weight gain following unilateral pallidotomy in Parkinson's disease , 2000, Acta neurologica Scandinavica.
[188] A. Kupsch,et al. Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease , 2008, European Journal of Clinical Pharmacology.
[189] G. Kerr,et al. Markers of Disease Severity Are Associated with Malnutrition in Parkinson's Disease , 2013, PloS one.
[190] F. Durif,et al. Parkinson's disease: A risk factor for osteoporosis. , 2015, Joint, bone, spine : revue du rhumatisme.
[191] G. Kerr,et al. Improved nutritional status is related to improved quality of life in Parkinson’s disease , 2014, BMC Neurology.
[192] M. Mazzola,et al. Body mass index does not change before Parkinson’s disease onset , 2008, European journal of neurology.
[193] A. Tomkins,et al. Diet, body size and micronutrient status in Parkinson's disease. , 1992, European journal of clinical nutrition.
[194] A. Tomkins,et al. Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. , 1992, Clinical science.
[195] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.
[196] K. Hanew,et al. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. , 2002, European journal of endocrinology.
[197] A L Benabid,et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients , 1999, Annals of neurology.
[198] L. T. Robertson,et al. Site of deep brain stimulation and jaw velocity in Parkinson disease. , 2011, Journal of neurosurgery.
[199] L. Forsgren,et al. Weight gain and increased central obesity in the early phase of Parkinson's disease. , 2014, Clinical nutrition.
[200] B. Bloem,et al. Weight loss in neurodegenerative disorders , 2008, Journal of Neurology.
[201] A. Gasbarrini,et al. Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[202] S. Fereshtehnejad,et al. Mini Nutritional Assessment (MNA) is Rather a Reliable and Valid Instrument to Assess Nutritional Status in Iranian Healthy Adults and Elderly with a Chronic Disease , 2015, Ecology of food and nutrition.
[203] S. Fereshtehnejad,et al. Prevalence of malnutrition in patients with Parkinson's disease: a comparative study with healthy controls using Mini Nutritional Assessment (MNA) questionnaire. , 2014, Journal of Parkinson's disease.
[204] Stuart Maudsley,et al. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. , 2012, Current Alzheimer research.
[205] M. Trail,et al. Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients , 2009, Movement disorders : official journal of the Movement Disorder Society.
[206] S. Fox,et al. Small intestinal bacterial overgrowth in Parkinson's disease. , 2014, Parkinsonism & related disorders.
[207] Bin Wu,et al. Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson’s disease , 2013, Neuroscience Bulletin.
[208] Ho-Won Lee,et al. Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naïve Parkinson’s Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study , 2016, PloS one.
[209] A. Quattrone,et al. Body Weight Influences Pharmacokinetics of Levodopa in Parkinson's Disease , 2002, Clinical neuropharmacology.
[210] N. Diederich,et al. Contributory Factors to Caregiver Burden in Parkinson Disease. , 2016, Journal of the American Medical Directors Association.
[211] D. Burke,et al. The response to muscle stretch and shortening in Parkinsonian rigidity. , 1972, Brain : a journal of neurology.